Cefazolin EP Impurity I
✓
100% accuracy
of data
24/7 scientific
support
⬡
0% tolerance in
quality of product

Stock Locations

  • New Jersey, USA
  • Czech Republic, EU
  • Mumbai, India

* Stock subject to availability.

Documentation

Download MSDS

Download Sample COA

Includes: HPLC, MASS/LC-MS, 1H NMR, FT-IR, Potency, Structure Elucidation Report (SER), and additional analytical data depending on the product.

1675244-99-1Cefazolin EP Impurity I

● In Stock

Catalogue No.:VE006873
CAS No.:1675244-99-1
Mol. Formula:C14H16N8O5S3
Mol. Weight:472.52 g/mol

Additional information on CAS 1675244-99-1

Parent drug

Cefazolin

IUPAC Name

2-[Carboxy[(1H-tetrazol-1-ylacetyl)amino]methyl]-5-[[(5-methyl-1,3,4-thia diazol-2-yl)sulfanyl]methyl]-5,6-dihydro-2H-1,3-thiazine-4-carboxylic acid

Synonyms

Cefazoloic Acid

Description

Cefazolin EP Impurity I, also designated cefazoloic acid, is a cephalosporin-derived process and degradation impurity associated with hydrolytic opening and rearrangement of the beta-lactam system. With CAS 1675244-99-1, molecular formula C14H16N8O5S3, and molecular weight 472.52 g/mol, it retains the thiazole and sulfonamide-rich scaffold characteristic of cefazolin-related species. Its structural complexity and polarity typically require reversed-phase LC coupled to diode-array detection and LC-MS/MS for definitive identification and quantification, with HRMS useful for fragment assignment. Regulatory evaluation considers it as a specified impurity in pharmacopeial control strategies rather than a classically genotoxic species.

Request a Quote

"*" indicates required fields

This field is for validation purposes and should be left unchanged.
Products quotation
Name
Url